Citation: | Chen Rongxin, Lai Xingqiang, Zhang Lei, et al. Analysis of risk factors and establishment of prediction model for post transplantation diabetes mellitus in renal transplant recipients[J]. ORGAN TRANSPLANTATION, 2021, 12(3): 329-335. doi: 10.3969/j.issn.1674-7445.2021.03.012 |
[1] |
NAGIB AM, ELSAYED MATTER Y, GHEITH OA, et al. Diabetic nephropathy following posttransplant diabetes mellitus[J]. Exp Clin Transplant, 2019, 17(2): 138-146. DOI: 10.6002/ect.2018.0157.
|
[2] |
CIMENO A, MUNLEY J, DRACHENBERG C, et al. Diabetic nephropathy after kidney transplantation in patients with pretransplantation type Ⅱ diabetes: a retrospective case series study from a high-volume center in the United States[J]. Clin Transplant, 2018, 32(12): e13425. DOI: 10.1111/ctr.13425.
|
[3] |
DUBOIS-LAFORGUE D. Post-transplantation diabetes mellitus in kidney recipients[J]. Nephrol Ther, 2017, 13(Suppl 1): S137-S146. DOI: 10.1016/j.nephro.2017.01.011.
|
[4] |
LIM WH, JOHNSON DW, HAWLEY CM, et al. Impact of diabetes mellitus on the association of vascular disease before transplantation with long-term transplant and patient outcomes after kidney transplantation: a population cohort study[J]. Am J Kidney Dis, 2018, 71(1): 102-111. DOI: 10.1053/j.ajkd.2017.08.018.
|
[5] |
CHANG S, JIANG J. Association of body mass index and the risk of new-onset diabetes after kidney transplantation: a Meta-analysis[J]. Transplant Proc, 2018, 50(5): 1316-1325. DOI: 10.1016/j.transproceed.2018.02.075.
|
[6] |
GULSOY KIRNAP N, BOZKUS Y, HABERAL M. Analysis of risk factors for posttransplant diabetes mellitus after kidney transplantation: single-center experience[J]. Exp Clin Transplant, 2020, 18(Suppl 1): 36-40. DOI: 10.6002/ect.TOND-TDTD2019.O8.
|
[7] |
LORHO R, HARDWIGSEN J, DUMORTIER J, et al. Regression of new-onset diabetes mellitus after conversion from tacrolimus to cyclosporine in liver transplant patients: results of a pilot study[J]. Clin Res Hepatol Gastroenterol, 2011, 35(6/7): 482-488. DOI: 10.1016/j.clinre.2011.03.008.
|
[8] |
OKUMI M, UNAGAMI K, HIRAI T, et al. Diabetes mellitus after kidney transplantation in Japanese patients: the Japan Academic Consortium of Kidney Transplantation study[J]. Int J Urol, 2017, 24(3): 197-204. DOI: 10.1111/iju.13253.
|
[9] |
CHENG CY, CHEN CH, WU MF, et al. Risk factors in and long-term survival of patients with post-transplantation diabetes mellitus: a retrospective cohort study[J]. Int J Environ Res Public Health, 2020, 17(12): 4581. DOI: 10.3390/ijerph17124581.
|
[10] |
GOMES V, FERREIRA F, GUERRA J, et al. New-onset diabetes after kidney transplantation: incidence and associated factors[J]. World J Diabetes, 2018, 9(7): 132-137. DOI: 10.4239/wjd.v9.i7.132.
|
[11] |
中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2017年版)[J]. 中国实用内科杂志, 2018, 38(4): 292-344. DOI: 10.19538/j.nk2018040108.
Branch of Diabetes of Chinese Medical Association. Guidelines for the prevention and control of type 2 diabetes in China (2017 edition)[J]. Chin J Pract Intern Med, 2018, 38(4): 292-344. DOI: 10.19538/j.nk2018040108.
|
[12] |
WIESBAUER F, HEINZE G, REGELE H, et al. Glucose control is associated with patient survival in diabetic patients after renal transplantation[J]. Transplantation, 2010, 89(5): 612-619. DOI: 10.1097/TP.0b013e3181c6ffa4.
|
[13] |
COSIO FG, PESAVENTO TE, KIM S, et al. Patient survival after renal transplantation: IV. impact of post-transplant diabetes[J]. Kidney Int, 2002, 62(4): 1440-1446. DOI: 10.1111/j.1523-1755.2002.kid582.x.
|
[14] |
王周城, 许南炜, 刘宇, 等. 免疫检查点抑制剂介导型糖尿病的研究进展[J]. 实用医学杂志, 2020, 36(18): 2474-2477, 2482. DOI: 10.3969/j.issn.1006-5725.2020. 18.004.
WANG ZC, XU NW, LIU Y, et al. Research progress on immune checkpoint inhibitor mediated diabetes mellitus[J]. J Pract Med, 2020, 36(18): 2474-2477, 2482. DOI: 10.3969/j.issn.1006-5725.2020.18.004.
|
[15] |
SHI D, XIE T, DENG J, et al. CYP3A4 and GCK genetic polymorphisms are the risk factors of tacrolimus-induced new-onset diabetes after transplantation in renal transplant recipients[J]. Eur J Clin Pharmacol, 2018, 74(6): 723-729. DOI: 10.1007/s00228-018-2442-4.
|
[16] |
XU J, XU L, WEI X, et al. Incidence and risk factors of posttransplantation diabetes mellitus in living donor kidney transplantation: a single-center retrospective study in China[J]. Transplant Proc, 2018, 50(10): 3381-3385. DOI: 10.1016/j.transproceed.2018.08.007.
|
[17] |
KARCZEWSKI J, ŚLEDZIŃSKA E, BATURO A, et al. Obesity and inflammation[J]. Eur Cytokine Netw, 2018, 29(3): 83-94. DOI: 10.1684/ecn.2018.0415.
|
[18] |
ZATTERALE F, LONGO M, NADERI J, et al. Chronic adipose tissue inflammation linking obesity to insulin resistance and type 2 diabetes[J]. Front Physiol, 2020, 10: 1607. DOI: 10.3389/fphys.2019.01607.
|
[19] |
WU D, DAWSON NA, LEVINGS MK. Obesity-associated adipose tissue inflammation and transplantation[J]. Am J Transplant, 2016, 16(3): 743-750. DOI: 10.1111/ajt.13578.
|
[20] |
GUZMÁN GE, VICTORIA AM, RAMOS I, et al. Risk factors related to new-onset diabetes after renal transplantation in patients of a high complexity University Hospital in Colombia, 20 years of experience[J]. Int J Endocrinol, 2020: 8297192. DOI: 10.1155/2020/8297192.
|
[21] |
赖兴强, 张磊, 方佳丽, 等. 肾移植术后新发糖尿病危险因素分析[J]. 中华内分泌外科杂志, 2019, 13(6): 450-455. DOI: 10.3760/cma.j.issn.1674-6090.2019.06.003.
LAI XQ, ZHANG L, FANG JL, et al. Analysis of risk factors for post-transplant diabetes mellitus in patients with renal transplants[J]. Chin J Endocr Surg, 2019, 13(6): 450-455. DOI: 10.3760/cma.j.issn.1674-6090.2019.06.003.
|
[22] |
CASCAIS DE SÁ D, SANTOS L, RODRIGUES L, et al. Post-kidney-transplant diabetes: evaluation of risk factors[J]. Transplant Proc, 2019, 51(5): 1597-1600. DOI: 10.1016/j.transproceed.2019.02.021.
|
[23] |
YU H, KIM H, BAEK CH, et al. Risk factors for new-onset diabetes mellitus after living donor kidney transplantation in Korea - a retrospective single center study[J]. BMC Nephrol, 2016, 17(1): 106. DOI: 10.1186/s12882-016-0321-8.
|
[24] |
American Diabetes Association. Improving care and promoting health in populations: standards of medical care in diabetes-2020[J]. Diabetes Care, 2020, 43(Suppl 1): S7-S13. DOI: 10.2337/dc20-S001.
|
[25] |
BANG JB, OH CK, KIM YS, et al. Insulin secretion and insulin resistance trajectories over 1 year after kidney transplantation: a multicenter prospective cohort study[J]. Endocrinol Metab (Seoul), 2020, 35(4): 820-829. DOI: 10.3803/EnM.2020.743.
|
[26] |
AHMED SH, BIDDLE K, AUGUSTINE T, et al. Post-transplantation diabetes mellitus[J]. Diabetes Ther, 2020, 11(4): 779-801. DOI: 10.1007/s13300-020-00790-5.
|
[27] |
WU K, CHENG Y, LI T, et al. The utility of HbA1c combined with haematocrit for early screening of gestational diabetes mellitus[J]. Diabetol Metab Syndr, 2018, 10: 14. DOI: 10.1186/s13098-018-0314-9.
|
[28] |
PAEK JH, KANG SS, PARK WY, et al. Incidence of post-transplantation diabetes mellitus within 1 year after kidney transplantation and related factors in Korean cohort study[J]. Transplant Proc, 2019, 51(8): 2714-2717. DOI: 10.1016/j.transproceed.2019.02.054.
|
[29] |
CHEWCHARAT A, PRASITLUMKUM N, THONGPRAYOON C, et al. Efficacy and safety of SGLT-2 inhibitors for treatment of diabetes mellitus among kidney transplant patients: a systematic review and Meta-analysis[J]. Med Sci (Basel), 2020, 8(4): 47. DOI: 10.3390/medsci8040047.
|
[30] |
TILLMANN FP, RUMP LC, QUACK I. HbA1c levels at 90 days after renal transplantation in non-diabetic recipients predict de novo pre-diabetes and diabetes at 1 and 3 years after transplantation[J]. Int Urol Nephrol, 2018, 50(8): 1529-1534. DOI: 10.1007/s11255-018-1917-7.
|
[31] |
ZHENG Y, LEY SH, HU FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications[J]. Nat Rev Endocrinol, 2018, 14(2): 88-98. DOI: 10.1038/nrendo.2017.151.
|
[32] |
朱高培, 孙娜, 许小珊, 等. 2型糖尿病风险评估模型和风险评分表的建立[J]. 中国卫生统计, 2019, 36(6): 843-846, 850. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGWT201906010.htm
ZHU GP, SUN N, XU XS, et al. Establishment of risk assessment model and risk scoretable for type 2 diabetes[J]. Chin J Health Stat, 2019, 36(6): 843-846, 850. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGWT201906010.htm
|
[33] |
文江平, 郝洁, 陶丽新, 等. 成年人2型糖尿病风险预测模型的建立[J]. 中华检验医学杂志, 2017, 40(9): 700-706. DOI: 10.3760/cma.j.issn.1009-9158.2017.09.013.
WEN JP, HAO J, TAO LX, et al. stablishment of the new risk model for prediction of type 2 diabetes[J]. Chin J Lab Med, 2017, 40(9): 700-706. DOI: 10.3760/cma.j.issn.1009-9158.2017.09.013.
|
[34] |
王蕾蕾, 潘洁, 曹素艳, 等. 不同糖尿病风险评分在体检人群中应用的效果评价[J]. 中华糖尿病杂志, 2018, 10(2): 123-127. DOI: 10.3760/cma.j.issn.1674-5809.2018.02.007.
WANG LL, PAN J, CAO SY, et al. Comparison of different diabetic risk score in health check-up population[J]. Chin J Diabetes Mellitus, 2018, 10(2): 123-127. DOI: 10.3760/cma.j.issn.1674-5809.2018.02.007.
|
[35] |
宋健, 吴学森, 张杰, 等. 三种统计学模型在糖尿病个体患病风险预测中的应用[J]. 中国卫生统计, 2017, 34(2): 312-314. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGWT201702039.htm
SONG J, WU XS, ZHANG J, et al. Application of three statistical models in predicting the risk of diabetes individuals[J]. Chin J Health Stat, 2017, 34(2): 312-314. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGWT201702039.htm
|
[36] |
陈渝, 宗会娟, 李伟. 2型糖尿病危险因素及患病风险预测模型研究[J]. 昆明理工大学学报(自然科学版), 2018, 43(2): 60-64, 70. DOI: 10.16112/j.cnki.53-1223/n.2018.02.009.
CHEN Y, ZONG HJ, LI W. A Research on risk factors and risk prediction models of type 2 diabetes mellitus[J]. J Kunming Univ Sci Technol (Nat Sci Edit), 2018, 43(2): 60-64, 70. DOI: 10.16112/j.cnki.53-1223/n.2018.02.009.
|
[37] |
马雨佳, 车前子, 郑启文, 等. 2型糖尿病发病风险预测模型常用评价方法[J]. 中国慢性病预防与控制, 2020, 28(2): 94-100. DOI: 10.16386/j.cjpccd.issn.1004-6194.2020.02.004.
MA YJ, CHE QZ, ZHENG QW, et al. Common evaluation methods of prediction model for risk of type 2 diabetes mellitus[J]. Chin J Prev Contr Chron Dis, 2020, 28(2): 94-100. DOI: 10.16386/j.cjpccd.issn.1004-6194.2020.02.004.
|
[38] |
唐慧, 张雪婷, 王翠喆, 等. 中国新疆地区肥胖、糖尿病前期和2型糖尿病检出率及民族分布特征[J]. 实用医学杂志, 2020, 36(10): 1381-1389. DOI:10.3969/j.issn. 1006-5725.2020.10.022.
TANG H, ZHANG XT, WANG CZ, et al. Detection rates and ethnic group distribution features of obesity, pre-diabetes and T2DM in Xinjiang, China[J]. J Pract Med, 2020, 36(10): 1381-1389. DOI:10.3969/j.issn.1006- 5725.2020.10.022.
|
[39] |
MUNSHI VN, SAGHAFIAN S, COOK CB, et al. Incidence, risk factors, and trends for postheart transplantation diabetes mellitus[J]. Am J Cardiol, 2020, 125(3): 436-440. DOI: 10.1016/j.amjcard.2019.10.054.
|
[40] |
ZIELIŃSKA K, KUKULSKI L, WRÓBEL M, et al. Prevalence and risk factors of new-onset diabetes after transplantation (NODAT)[J]. Ann Transplant, 2020, 25: e926556. DOI: 10.12659/AOT.926556.
|
[41] |
TOMKINS M, TUDOR RM, CRONIN K, et al. Risk factors and long-term consequences of new-onset diabetes after renal transplantation[J]. Ir J Med Sci, 2020, 189(2): 497-503. DOI: 10.1007/s11845-019-02112-6.
|
[42] |
JENSSEN T, HARTMANN A. Post-transplant diabetes mellitus in patients with solid organ transplants[J]. Nat Rev Endocrinol, 2019, 15(3): 172-188. DOI: 10.1038/s41574-018-0137-7.
|
[43] |
斌荣. SPSS 17.0在医学统计中的应用[M]. 北京: 科学出版社, 2017: 207-219.
|